Evaluation of cerebral blood flow regulation in children with congenital heart disease by transcranial color Doppler ultrasound

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041736

Enrollment

Unknown

Registered

2021-01-03

Start date

2021-01-15

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

Group Dexmedetomidine:Dexmedetomidine was given after induction

Group Pressure:After induction, give 30mmhg pressure higher than systolic blood pressure for 2 minutes

Eligibility

Sex/Gender

All

Age

No minimum to 6 Years

Inclusion criteria

Inclusion criteria: 1. Age: 0-18 years old; 2. Elective surgery for congenital heart disease; 3. Get informed consent from parents or guardians.

Exclusion criteria

Exclusion criteria: 1.ASA > III; 2.Emergency operation; 3.Previous nervous system diseases; 4.Fever before operation; 5.Use of sedative drugs, and the withdrawal time is less than 24 hours.

Design outcomes

Primary

Measure	Time frame
Cerebral blood flow;Cerebral oxygen saturation;	—

Countries

China

Contacts

Public ContactZheng Jijian

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

zhengjijian@scmc.com.cn+86 18964853803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026